Canaccord analyst Derek Dley raised the firm’s price target on Trulieve Cannabis to C$35 from C$33 and keeps a Buy rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TCNNF:
- Here’s What You Missed in Cannabis, Psychedelics This Week
- Trulieve Reports Fourth Quarter and Full Year 2023 Results Highlighting Year End Momentum and Cash Generation
- Rising High: Exclusive talk with cannabis market research firm BDSA
- Rising High: Exclusive talk with house of brands Carma HoldCo
- Rising High: Exclusive talk with drug manufacturer Optimi Health